论文信息 - Updated Results of a Phase II Randomized Study (ROMULUS) of Polatuzumab Vedotin or Pinatuzumab Vedotin Plus Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma - 字舞流文

Updated Results of a Phase II Randomized Study (ROMULUS) of Polatuzumab Vedotin or Pinatuzumab Vedotin Plus Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

R. Advani | A. Hagenbeek | G. Salles | L. Sehn | K. Kolibaba | I. Flinn | B. Cheson | H. Tilly | P. Zinzani | M. Dreyling | F. Morschhauser | O. Press | C. Diefenbach | D. Lu | J. Sharman | S. Assouline | Y. Chu | S. Yalamanchili | Surai Jones | Cheryl Jones | A. Chen | Sreeni Yalamanchili